MiMedx Group
MDXG
152 hedge funds and large institutions have $184M invested in MiMedx Group in 2022 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 40 reducing their positions, and 10 closing their positions.
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
25% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 40
6% more funds holding
Funds holding: 144 → 152 (+8)
1.57% more ownership
Funds ownership: 56.65% → 58.22% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less capital invested
Capital invested by funds: $185M → $184M (-$644K)
24% less call options, than puts
Call options by funds: $142K | Put options by funds: $188K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.43M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$2.12M |
| 3 |
BlackRock
New York
|
+$555K |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$526K |
| 5 |
RA
Royce & Associates
New York
|
+$448K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.55M |
| 2 |
RB
Richmond Brothers
Jackson,
Michigan
|
-$860K |
| 3 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$675K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$658K |
| 5 |
NC
NovaPoint Capital
Atlanta,
Georgia
|
-$355K |
MDXG Hedge Fund Activity: Q4 2022 in Review
152 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q4 2022, worth a combined $184M — down 0.35% from $185M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new MDXG positions and 10 closed out — a net gain of 11 holders — while 50 added to existing stakes and 40 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $3.43M. The largest seller was Federated Hermes, cutting an estimated $1.55M.
- 152 institutional investors held MiMedx Group (MDXG) as of Q4 2022, up from 144 in Q3 2022.
- Funds reported $184M of MiMedx Group stock for Q4 2022, down 0.35% quarter-over-quarter.
- 21 funds opened new MiMedx Group positions in Q4 2022 and 10 closed out, a net change of +11 holders.
- The largest MiMedx Group buyer in Q4 2022 was Nantahala Capital Management, an estimated $3.43M added.
- The largest MiMedx Group seller in Q4 2022 was Federated Hermes, an estimated $1.55M sold.
Based on aggregated 13F filings for Q4 2022.